Background Rheumatoid arthritis (RA) patients carry a high risk of cardiovascular morbidity
and mortality. The excess of cardiovascular disease cannot be entirely explained by …

Background Antibodies against carbamylated proteins (anti-CarP) have been recently
identified in the sera of patients with rheumatoid arthritis (RA). The objective of the study was …

Objectives: To evaluate levels of anti-carbamylated protein (anti-CarP) antibodies in
rheumatoid arthritis (RA) patients and to determine their association with serological …

Objective Citrullinated proteins have been found within atherosclerotic plaque. However,
studies evaluating the association between anti–citrullinated protein antibodies (ACPAs) …

Objective The presence of anti-citrullinated protein antibodies (ACPA) and IgM-rheumatoid
factor (IgM-RF) years before the clinical diagnosis of rheumatoid arthritis (RA) suggests they …

A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies,
which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated …

Background Anti-carbamylated protein (anti-CarP) antibodies have recently been reported
to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and …

Objective Recently, we discovered a new autoantibody system in rheumatoid arthritis (RA):
anti–carbamylated protein (anti‐CarP) antibodies. These antibodies have value in predicting …

Introduction The presence of a new autoantibody system, anti-carbamylated protein (anti-
CarP) antibodies, has been identified in rheumatoid arthritis (RA). The presence of anti-CarP …

Coronary heart disease is the main cause of mortality in patients with rheumatoid arthritis
(RA), a disease known to be associated with accelerated atherosclerosis. The role of …